125 related articles for article (PubMed ID: 38844365)
1. Role of Mitogen-activated protein kinase kinase kinase kinase 4 signaling in liver and metabolic diseases.
Ampadu F; Awasthi V; Joshi AD
J Pharmacol Exp Ther; 2024 Jun; ():. PubMed ID: 38844365
[TBL] [Abstract][Full Text] [Related]
2. MAP4K4: an emerging therapeutic target in cancer.
Gao X; Gao C; Liu G; Hu J
Cell Biosci; 2016; 6():56. PubMed ID: 27800153
[TBL] [Abstract][Full Text] [Related]
3. Map4k4 Signaling Nodes in Metabolic and Cardiovascular Diseases.
Virbasius JV; Czech MP
Trends Endocrinol Metab; 2016 Jul; 27(7):484-492. PubMed ID: 27160798
[TBL] [Abstract][Full Text] [Related]
4. Mitogen-activated protein kinase kinase kinase kinase 4 as a putative effector of Rap2 to activate the c-Jun N-terminal kinase.
Machida N; Umikawa M; Takei K; Sakima N; Myagmar BE; Taira K; Uezato H; Ogawa Y; Kariya K
J Biol Chem; 2004 Apr; 279(16):15711-4. PubMed ID: 14966141
[TBL] [Abstract][Full Text] [Related]
5. Map4k4 suppresses Srebp-1 and adipocyte lipogenesis independent of JNK signaling.
Danai LV; Guilherme A; Guntur KV; Straubhaar J; Nicoloro SM; Czech MP
J Lipid Res; 2013 Oct; 54(10):2697-707. PubMed ID: 23924694
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of MAP4K4 signaling initiates metabolic reprogramming to protect hepatocytes from lipotoxic damage.
Anand SK; Caputo M; Xia Y; Andersson E; Cansby E; Kumari S; Henricsson M; Porosk R; Keuenhof KS; Höög JL; Nair S; Marschall HU; Blüher M; Mahlapuu M
J Lipid Res; 2022 Jul; 63(7):100238. PubMed ID: 35679904
[TBL] [Abstract][Full Text] [Related]
7. Molecular Insights of MAP4K4 Signaling in Inflammatory and Malignant Diseases.
Singh SK; Roy R; Kumar S; Srivastava P; Jha S; Rana B; Rana A
Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190200
[TBL] [Abstract][Full Text] [Related]
8. Inducible Deletion of Protein Kinase Map4k4 in Obese Mice Improves Insulin Sensitivity in Liver and Adipose Tissues.
Danai LV; Flach RJ; Virbasius JV; Menendez LG; Jung DY; Kim JH; Kim JK; Czech MP
Mol Cell Biol; 2015 Jul; 35(13):2356-65. PubMed ID: 25918248
[TBL] [Abstract][Full Text] [Related]
9. MAP4K4 gene silencing in human skeletal muscle prevents tumor necrosis factor-alpha-induced insulin resistance.
Bouzakri K; Zierath JR
J Biol Chem; 2007 Mar; 282(11):7783-9. PubMed ID: 17227768
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor alpha (TNFalpha) stimulates Map4k4 expression through TNFalpha receptor 1 signaling to c-Jun and activating transcription factor 2.
Tesz GJ; Guilherme A; Guntur KV; Hubbard AC; Tang X; Chawla A; Czech MP
J Biol Chem; 2007 Jul; 282(27):19302-12. PubMed ID: 17500068
[TBL] [Abstract][Full Text] [Related]
11. Silencing of Long Non-coding RNA GAS5 Suppresses Neuron Cell Apoptosis and Nerve Injury in Ischemic Stroke Through Inhibiting DNMT3B-Dependent MAP4K4 Methylation.
Deng Y; Chen D; Gao F; Lv H; Zhang G; Sun X; Liu L; Mo D; Ma N; Song L; Huo X; Yan T; Zhang J; Luo Y; Miao Z
Transl Stroke Res; 2020 Oct; 11(5):950-966. PubMed ID: 31997156
[TBL] [Abstract][Full Text] [Related]
12. The Ste20 Family Kinases MAP4K4, MINK1, and TNIK Converge to Regulate Stress-Induced JNK Signaling in Neurons.
Larhammar M; Huntwork-Rodriguez S; Rudhard Y; Sengupta-Ghosh A; Lewcock JW
J Neurosci; 2017 Nov; 37(46):11074-11084. PubMed ID: 28993483
[TBL] [Abstract][Full Text] [Related]
13. MAP4K4 promotes epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma.
Feng XJ; Pan Q; Wang SM; Pan YC; Wang Q; Zhang HH; Zhu MH; Zhang SH
Tumour Biol; 2016 Aug; 37(8):11457-67. PubMed ID: 27010469
[TBL] [Abstract][Full Text] [Related]
14. RBM4a-SRSF3-MAP4K4 Splicing Cascade Constitutes a Molecular Mechanism for Regulating Brown Adipogenesis.
Peng HY; Liang YC; Tan TH; Chuang HC; Lin YJ; Lin JC
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30200638
[TBL] [Abstract][Full Text] [Related]
15. MAP4K4 expression in cardiomyocytes: multiple isoforms, multiple phosphorylations and interactions with striatins.
Fuller SJ; Edmunds NS; McGuffin LJ; Hardyman MA; Cull JJ; Alharbi HO; Meijles DN; Sugden PH; Clerk A
Biochem J; 2021 Jun; 478(11):2121-2143. PubMed ID: 34032269
[TBL] [Abstract][Full Text] [Related]
16. Identification of Map4k4 as a novel suppressor of skeletal muscle differentiation.
Wang M; Amano SU; Flach RJ; Chawla A; Aouadi M; Czech MP
Mol Cell Biol; 2013 Feb; 33(4):678-87. PubMed ID: 23207904
[TBL] [Abstract][Full Text] [Related]
17. MAP4K4 is involved in the neuronal development of retinal photoreceptors.
Huang H; Kuang X; Zou Y; Zeng J; Du H; Tang H; Long C; Mao Y; Yu X; Wen C; Yan J; Shen H
Exp Eye Res; 2023 Aug; 233():109524. PubMed ID: 37290629
[TBL] [Abstract][Full Text] [Related]
18. MAP4K4 Is a Threonine Kinase That Phosphorylates FARP1.
Schwaid AG; Su C; Loos P; Wu J; Nguyen C; Stone KL; Kanyo J; Geoghegan KF; Bhattacharya SK; Dow RL; Buckbinder L; Carpino PA
ACS Chem Biol; 2015 Dec; 10(12):2667-71. PubMed ID: 26422651
[TBL] [Abstract][Full Text] [Related]
19. MAP4K4 and cancer: ready for the main stage?
González-Montero J; Rojas CI; Burotto M
Front Oncol; 2023; 13():1162835. PubMed ID: 37223681
[TBL] [Abstract][Full Text] [Related]
20. MAP4K4 deletion inhibits proliferation and activation of CD4(+) T cell and promotes T regulatory cell generation in vitro.
Huang H; Tang Q; Chu H; Jiang J; Zhang H; Hao W; Wei X
Cell Immunol; 2014; 289(1-2):15-20. PubMed ID: 24681727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
